Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/pregabalin-gabapentin/
CompareKey points for this combination
Drowsiness, impaired coordination. Respiratory concern increases with additional risk factors [12]
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
Additive sedation, impaired consciousness or protective reflexes, and possible respiratory consequences
Sources
Check the review’s wording
Sedation, ataxia; respiratory concern increases with additional risk factors [12]
- [12] FDA. Gabapentin and Pregabalin Drug Safety Communication. Respiratory safety warning; not a DXM study. [Source](https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication) · Open publication